Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) Peptide
PARK2
Host: Synthetic
BP, WB, IHC
-
- Target See all Parkin (PARK2) products
- Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Purpose
- E3 Ubiquitin-Protein Ligase Parkin, Parkin RBR E3 ubiquitin-protein ligase, Parkinson Juvenile Disease Protein 2, PARK2, PRKN
- Sequence
- Peptide (C)KELHHFRILG EEQYTR, correspond ing to amino acid residues 298 - 313 of mouse Parkin (Accession Q9WVS6).
- Characteristics
- A Blocking peptide for Anti-Parkin Antibody (#ABIN7237754).
- Purity
- >70 %
-
-
- Application Notes
- Antigen Preadsorption Control: 1 μg peptide per 1 μg antibody.
- Comment
-
Confirmed by amino acid analysis and mass spectrometry.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- 100 μL double distilled water (DDW).
- Concentration
- 0.4 mg/mL
- Storage
- RT,-20 °C
- Storage Comment
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
- Target
- Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
- Synonyms
- CG10523 Peptide, Dmel\\CG10523 Peptide, Dpark Peptide, SD01679 Peptide, dpk Peptide, AR-JP Peptide, LPRS2 Peptide, PDJ Peptide, PRKN Peptide, Park Peptide, Prkn Peptide, si:ch211-123f21.1 Peptide, zgc:112390 Peptide, pdr-1 Peptide, PARK2 Peptide, parkin Peptide, parkin RBR E3 ubiquitin protein ligase Peptide, Parkinson disease (autosomal recessive, juvenile) 2, parkin Peptide, park Peptide, PRKN Peptide, Prkn Peptide, prkn Peptide, CpipJ_CPIJ014867 Peptide, Park2 Peptide
-
You are here:
